Democratic Congresswoman representing California's 18th District (Silicon Valley), and the ranking member of the Communications and Technology Subcommittee
Anna Eshoo on KCRW
More from KCRW
Can Israel decide who qualifies as Jewish?
PoliticsThe genocide in Gaza has brought the issue of Israel — and what it represents for Jewish people — into the forefront of Jewish communities worldwide.
Another sales tax for homeless services: LA voters to decide
Election 2024Measure A – on LA County ballots this November – asks voters whether or not to approve a sales tax hike to fund homeless services and affordable housing.
Donald Trump’s massive win makes way for red wave
PoliticsKCRW analyzes Donald Trump’s presidential win. Did the Democrats play a losing hand? Plus, what can we expect under the leadership of a conservative government?
US legislators harden stance on China, Brazil bans Musk’s X
PoliticsThe U.S. continues to take a firm stance on China. When does censorship go too far? Plus, California’s gas inventory may hurt its neighboring state, Nevada.
Anaheim failed to pass $50 limit on lobbying gifts to city officials
Orange CountyThe Anaheim City Council postponed their vote on a proposed ordinance to set a $50 limit for gifts to council members.
Juan Cole: Where is the Middle East Heading?
PoliticsIn the 365 days following the events of Oct. 7, the situation in the Middle East is as complicated as ever.
Should we re-frame our idea of ‘working class’ voters?
PoliticsDoes “working class” mean what it used to? Is fracking getting more attention than it deserves? Plus, KCRW examines what came out of one culture war in Lancaster, Pennsylvania.
What are the differences between conservatism, Trumpism, and GOP?
PoliticsWhat is a “never Trump” Republican? Both Trump and Harris are trying to win over swing and Centrist voters. Plus, conflict in the Middle East turns to Lebanon.
Irvine police buys $150K Cybertruck, critics call it unnecessary
LawThe Irvine Police Department purchased a Tesla Cybertruck to promote its D.A.R.E drug program. But some taxpayers say the money should be spent elsewhere.